Long-term experience with high-flux polysulfone in hemodialysis. 1994

G Civati, and U Teatini, and C Guastoni, and A Perego, and M L Perrino, and L Ballerini, and L Minetti
Divisione di Nefrologia e Dialisi, Ospedale Niguarda Cà-Granda, Milano, Italy.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007688 Kidneys, Artificial Devices which can substitute for normally functioning KIDNEYS in removing components from the blood by DIALYSIS that are normally eliminated in the URINE. Artificial Kidney,Kidney, Artificial,Artificial Kidneys,Blood Dialyser,Blood Dialyzers,Hemodialyser,Hemodialyzers,Renal Dialysis Machine,Blood Dialysers,Blood Dialyzer,Dialyser, Blood,Dialysers, Blood,Dialysis Machine, Renal,Dialysis Machines, Renal,Dialyzer, Blood,Dialyzers, Blood,Hemodialysers,Hemodialyzer,Machine, Renal Dialysis,Machines, Renal Dialysis,Renal Dialysis Machines
D008297 Male Males
D008567 Membranes, Artificial Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION. Artificial Membranes,Artificial Membrane,Membrane, Artificial
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001672 Biocompatible Materials Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function. Biomaterials,Bioartificial Materials,Hemocompatible Materials,Bioartificial Material,Biocompatible Material,Biomaterial,Hemocompatible Material,Material, Bioartificial,Material, Biocompatible,Material, Hemocompatible
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

G Civati, and U Teatini, and C Guastoni, and A Perego, and M L Perrino, and L Ballerini, and L Minetti
April 2000, European journal of clinical pharmacology,
G Civati, and U Teatini, and C Guastoni, and A Perego, and M L Perrino, and L Ballerini, and L Minetti
December 1996, Clinical pharmacology and therapeutics,
G Civati, and U Teatini, and C Guastoni, and A Perego, and M L Perrino, and L Ballerini, and L Minetti
March 1965, Annals of internal medicine,
G Civati, and U Teatini, and C Guastoni, and A Perego, and M L Perrino, and L Ballerini, and L Minetti
November 2000, European journal of clinical pharmacology,
G Civati, and U Teatini, and C Guastoni, and A Perego, and M L Perrino, and L Ballerini, and L Minetti
May 1997, Wiener klinische Wochenschrift,
G Civati, and U Teatini, and C Guastoni, and A Perego, and M L Perrino, and L Ballerini, and L Minetti
January 2002, Blood purification,
G Civati, and U Teatini, and C Guastoni, and A Perego, and M L Perrino, and L Ballerini, and L Minetti
February 2002, Nephron,
G Civati, and U Teatini, and C Guastoni, and A Perego, and M L Perrino, and L Ballerini, and L Minetti
January 2014, Przeglad lekarski,
G Civati, and U Teatini, and C Guastoni, and A Perego, and M L Perrino, and L Ballerini, and L Minetti
December 2009, Clinical journal of the American Society of Nephrology : CJASN,
G Civati, and U Teatini, and C Guastoni, and A Perego, and M L Perrino, and L Ballerini, and L Minetti
September 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Copied contents to your clipboard!